“Fusion and binding inhibition” key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches

More than 35 million people are living with HIV worldwide with approximately 2.3 million new infections per year. Cascade of events (cell entry, virus replication, assembly and release of newly formed virions) is involved in the HIV-1 transmission process. Every single step offers a potential therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Tanushree, Chauhan, Gaurav, Rath, Goutam, Murthy, R. S. R., Goyal, Amit K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241151/
https://www.ncbi.nlm.nih.gov/pubmed/28240046
http://dx.doi.org/10.1080/10717544.2016.1228717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241151/
https://www.ncbi.nlm.nih.gov/pubmed/28240046
http://dx.doi.org/10.1080/10717544.2016.1228717

Ejemplares similares